Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
FASEB Bioadvances
|
May 8, 2023
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy
Amiee Dowdell, Mark Marsland, Sam Faulkner, et al.
Scientific Reports
|
February 1, 2020
Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion
Christopher W Rowe, Tony Dill, Nathan Griffin, et al.
FASEB Bioadvances
|
July 18, 2020
Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma
Sam Faulkner, Nathan Griffin, Christopher W Rowe, et al.
Oncotarget
|
April 14, 2016
ProNGF is a potential diagnostic biomarker for thyroid cancer
Sam Faulkner, Severine Roselli, Yohann Demont, et al.
The American Journal of Pathology
|
June 12, 2020
The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion
Fangfang Gao, Nathan Griffin, Sam Faulkner, et al.
Cancers
|
August 29, 2024
CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial
Mark Marsland, Chen Chen Jiang, Sam Faulkner, et al.
International Journal of Molecular Sciences
|
November 29, 2019
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables
Christopher W Rowe, Tony Dill, Sam Faulkner, et al.
Oncotarget
|
April 15, 2015
Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion
Séverine Roselli, Jay Pundavela, Yohann Demont, et al.
Oncogene
|
November 17, 2021
Tumor innervation is triggered by endoplasmic reticulum stress
Chen Chen Jiang, Mark Marsland, Yufang Wang, et al.
BMC Endocrine Disorders
|
November 29, 2019
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
Christopher W Rowe, Sam Faulkner, Jonathan W Paul, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
FASEB Bioadvances
|
May 8, 2023
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy
Amiee Dowdell, Mark Marsland, Sam Faulkner, et al.
Scientific Reports
|
February 1, 2020
Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion
Christopher W Rowe, Tony Dill, Nathan Griffin, et al.
FASEB Bioadvances
|
July 18, 2020
Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma
Sam Faulkner, Nathan Griffin, Christopher W Rowe, et al.
Oncotarget
|
April 14, 2016
ProNGF is a potential diagnostic biomarker for thyroid cancer
Sam Faulkner, Severine Roselli, Yohann Demont, et al.
The American Journal of Pathology
|
June 12, 2020
The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion
Fangfang Gao, Nathan Griffin, Sam Faulkner, et al.
Cancers
|
August 29, 2024
CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial
Mark Marsland, Chen Chen Jiang, Sam Faulkner, et al.
International Journal of Molecular Sciences
|
November 29, 2019
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables
Christopher W Rowe, Tony Dill, Sam Faulkner, et al.
Oncotarget
|
April 15, 2015
Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion
Séverine Roselli, Jay Pundavela, Yohann Demont, et al.
Oncogene
|
November 17, 2021
Tumor innervation is triggered by endoplasmic reticulum stress
Chen Chen Jiang, Mark Marsland, Yufang Wang, et al.
BMC Endocrine Disorders
|
November 29, 2019
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
Christopher W Rowe, Sam Faulkner, Jonathan W Paul, et al.
Page
of 4